UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.269

Sortiert nach

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical therapeutics, 2016-09, Vol.38 (9), p.2058-2070.e1

2016

Link zum Volltext

Verfügbarkeit prüfen

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Allergy (Copenhagen), 2019-09, Vol.74 (9), p.1716-1726

2019

Link zum Volltext

Verfügbarkeit prüfen

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)

The European respiratory journal, 2022-01, Vol.59 (1), p.2100396

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study

Clinical therapeutics, 2019-10, Vol.41 (10), p.2041-2056.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Frontiers in immunology, 2023-04, Vol.14, p.1150162-1150162

2023

Link zum Volltext

Verfügbarkeit prüfen

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics

Respiratory research, 2021-05, Vol.22 (1), p.144-144, Article 144

2021

Link zum Volltext

Verfügbarkeit prüfen

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

Respiratory research, 2019-05, Vol.20 (1), p.83-83, Article 83

2019

Link zum Volltext

Verfügbarkeit prüfen

Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health

Biomarker Insights, 2022-07, Vol.17, p.117727192211118-11772719221111882

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

Respiratory research, 2022-03, Vol.23 (1), p.45-45, Article 45

2022

Link zum Volltext

Verfügbarkeit prüfen

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs

Frontiers in microbiology, 2023-04, Vol.14, p.1085818-1085818

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study

BMC pediatrics, 2022-07, Vol.22 (1), p.1-429, Article 429

2022

Link zum Volltext

Verfügbarkeit prüfen

Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity-Current Status and Expected Future Trends

Toxins, 2021-11, Vol.13 (12), p.848

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Journal of allergy and clinical immunology, 2019-05, Vol.143 (5), p.1742-1751.e7

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid detection of Escherichia coli in water using a hand-held fluorescence detector

Water research (Oxford), 2010-04, Vol.44 (8), p.2621-2628

2010

Link zum Volltext

Verfügbarkeit prüfen

Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports

Clinical and translational allergy, 2021-10, Vol.11 (8), p.e12067-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype

Journal of allergy and clinical immunology, 2019-11, Vol.144 (5), p.1336-1342.e7

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab

ERJ open research, 2022-04, Vol.8 (2), p.560

2022

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Pediatric pulmonology, 2019-12, Vol.54 (12), p.1957-1967

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2021-05, Vol.20 (3), p.551-562

2021

Link zum Volltext

Verfügbarkeit prüfen

Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies

Journal of allergy and clinical immunology, 2017-11, Vol.140 (5), p.1464-1466.e4

2017

Link zum Volltext

Verfügbarkeit prüfen

REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-10, Vol.10 (10), p.2646-2656

2022

Link zum Volltext

Verfügbarkeit prüfen

Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-12, Vol.11 (12), p.3650-3661.e3

2023

Link zum Volltext

Verfügbarkeit prüfen

Escherichia coli contamination of the river Thames in different seasons and weather conditions

Water and environment journal : WEJ, 2012-12, Vol.26 (4), p.482-489

2012

Link zum Volltext

Verfügbarkeit prüfen

Cadmium Nephropathy and Smoking

Clinical Medicine Insights: Urology, 2017-01, Vol.2017 (10), p.117956111772609

Price, Robert G

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure–function relationships of the extracellular domain of the autosomal dominant polycystic kidney disease-associated protein, polycystin-1

FEBS Letters, 2003-03, Vol.538 (1-3), p.8-13

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.156)
Mit Volltextzugriff
(1.113)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(889)
Life Sciences & Biomedicine
(752)
Humans
(642)
Male
(366)
Female
(355)
Biological And Medical Sciences
(273)
Middle Aged
(228)
Medical Sciences
(204)
Adult
(198)
Aged
(168)
Animals
(154)
Neurosciences & Neurology
(106)
Physical Sciences
(89)
Risk Factors
(85)
Fundamental And Applied Biological Sciences. Psychology
(77)
Neurosciences
(77)
Science & Technology - Other Topics
(74)
Multidisciplinary Sciences
(71)
Treatment Outcome
(71)
Medicin Och Hälsovetenskap
(70)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs

The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study

Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity-Current Status and Expected Future Trends

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Rapid detection of Escherichia coli in water using a hand-held fluorescence detector

Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports

Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing

Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies

REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma

Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis

Escherichia coli contamination of the river Thames in different seasons and weather conditions

Cadmium Nephropathy and Smoking

Structure–function relationships of the extracellular domain of the autosomal dominant polycystic kidney disease-associated protein, polycystin-1

Suchergebnisse filtern